Ammar Al-Chalabi is a Clinician Scientist at King’s College London. His research focuses on causes, modifiers and potential treatments for ALS. He co-leads the UK MND Research Institute, chairs the International Symposium on ALS/MND, and is a National Institute for Health Research Senior Investigator. His work has been recognized by multiple honours, including the Forbes Norris Award from the International Alliance of ALS/MND Associations, the Healey Center International Prize for Innovation in ALS, the Sheila Essey Award from the American Academy of Neurology, the Charcot Young Investigator Award from the MND Association, and Fellowship of the Academy of Medical Sciences.